Details of the Drug

General Information of Drug (ID: DMFMNZB)

Drug Name

Lmprime P66

Indication

Disease Entry	ICD 11	Status	REF
leukaemia	2A60-2B33	Phase 3	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01309126) Study of Imprime PGG in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer. U.S. National Institutes of Health.